After discussing the information, documents and findings acquired in the preliminary inquiry conducted about the claim of bid rigging in tenders for preparing chemotherapy medicine in its meeting of 18.01.2018, the Board concluded that the findings were significant and sufficient, and took the decision no 18-03/30-M to initiate an investigation about the following undertakings to decide whether they violated article 4 of the Act no. 4054:

• Oncosem Onkolojik Sistemler San. ve Tic. A.Ş.,
• Santek Sağlık Turz. Teks. San. ve Tic. A.Ş.,
• Meditera İthalat ve İhracat A.Ş.,
• Onkofar Sağlık Ürünleri San. ve Tic. A.Ş.,
• İnvotek Sağlık Teknolojileri Tic. Ltd. Şti.,
• Korulu Grup Sağlık Hizmet İnşaat Taahhüt Makina Temizlik San. ve Tic. Ltd. Şti.

*Investigation decisions taken by the Competition Board are announced to the public following the notification of the decision to the undertakings or associations of undertakings under investigation. Those announcements, which are made within the framework of informing the public about the decisions of the Competition Board, cannot be interpreted to mean that the undertakings or associations of undertakings under investigation have violated the Act no 4054, or they are or will be subject to penal sanctions under the Act.